KemPharm Announces Entry into Definitive Collaboration and License Agreement for its ADHD Candidates, KP415 and KP484, with an Affiliate of Gurnet Point Capital

September 4, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search